Table 1.
Training cohort (n = 112) | Testing cohort (n = 47) | ||||
---|---|---|---|---|---|
TERTp-mutation | TERTp-wildtype | TERTp-mutation | TERTp-wildtype | P | |
Characteristic | (n = 90) | (n = 22) | (n = 38) | (n = 9) | 0.8958 |
Age, years | 58.1 ± 12.3 | 59.2 ± 11.2 | 0.3699 | ||
Sex | |||||
Female | 45 (40.2%) | 17 (54.8%) | 0.1449 | ||
Male | 67 (59.8%) | 14 (45.2%) | |||
WHO grade | |||||
III | 39 (34.8%) | 14 (29.8%) | 0.5389 | ||
IV | 73 (65.2%) | 33 (70.2%) |
Data are means ± standard deviations or numbers of patients with percentages in parentheses. P value was derived from the univariate association analyses between each clinical parameter. Calculated by using the independent sample t test for continuous variables and the χ2 test for categoric variables